Cargando…

Second-Generation Antipsychotic Discontinuation in First Episode Psychosis: An Updated Review

"All-causes discontinuation" refers to discontinuation of treatment for any reason, and medication adherence is an important component of this measure. Similar to our previous results, we found that almost 30% of patients with first-episode psychosis (FEP) discontinue medication in the fir...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miller, Brian J., Bodenheimer, Chelsea, Crittenden, Krystle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean College of Neuropsychopharmacology 2011
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3569083/ https://www.ncbi.nlm.nih.gov/pubmed/23429653 http://dx.doi.org/10.9758/cpn.2011.9.2.45

Ejemplares similares

Divergent effects of first-generation and second-generation antipsychotics on cortical thickness in first-episode psychosis
por: Ansell, B. R. E., et al.
Publicado: (2015)

The effect of second-generation antipsychotics on hippocampal volume in first episode of psychosis: longitudinal study
por: Bodnar, Michael, et al.
Publicado: (2016)

A systematic review of comparative time to all cause discontinuation of antipsychotic medications in first episode psychosis
por: Brooke, Alice, et al.
Publicado: (2021)

T121. RATES AND PREDICTORS OF RELAPSE FOLLOWING DISCONTINUATION OF ANTIPSYCHOTIC MEDICATION AFTER A FIRST EPISODE OF PSYCHOSIS
por: Bowtell, Meghan, et al.
Publicado: (2018)

Maintenance antipsychotic treatment versus discontinuation strategies following remission from first episode psychosis: systematic review
por: Thompson, Andrew, et al.
Publicado: (2018)

S145. ANTIPSYCHOTIC DISCONTINUATION IN FIRST EPISODE PSYCHOSIS: [18F]DOPA AND [11C]RACLOPRIDE PET STUDY
por: Kim, Euitae
Publicado: (2018)

Discontinuing Antipsychotic Medication After Remission from First-Episode Psychosis: A Survey of Psychiatrists’ Attitudes in Taiwan
por: Yen, Ko, et al.
Publicado: (2022)

Antipsychotic prescribing choices in patients with First Episode Psychosis
por: Fallon, J., et al.
Publicado: (2022)

Gradients of striatal function in antipsychotic-free first-episode psychosis and schizotypy
por: Oldehinkel, Marianne, et al.
Publicado: (2023)

Antipsychotic pharmacogenomics in first episode psychosis: a role for glutamate genes
por: Stevenson, J M, et al.
Publicado: (2016)

Multidimensional predictors of negative symptoms in antipsychotic-naive first-episode psychosis
por: Toll, Alba, et al.
Publicado: (2022)

The benefits of the Mediterranean diet in first episode psychosis patients taking antipsychotics
por: Vassilopoulou, Emilia, et al.
Publicado: (2022)

Childhood trauma, antipsychotic medication, and symptom remission in first-episode psychosis
por: Ottesen, Akiah, et al.
Publicado: (2023)

Factors Influencing the Use of Second-Generation Antipsychotics in Children with Psychosis
por: Ramachandran, Sujith, et al.
Publicado: (2016)

Efficacy of second-generation antipsychotics in patients at ultra-high risk and those with first-episode or multi-episode schizophrenia
por: Washida, Kenji, et al.
Publicado: (2013)

Schneider’s first-rank symptoms as predictors of remission in antipsychotic-naive first-episode psychosis
por: Malinowski, Fernando R., et al.
Publicado: (2019)

Antipsychotic Treatment Reduces Indices of Oxidative Stress in First-Episode Psychosis Patients
por: Kriisa, Kärt, et al.
Publicado: (2016)

Effectiveness of antipsychotics used in first-episode psychosis: a naturalistic cohort study
por: Whale, Richard, et al.
Publicado: (2016)

A Meta-Analysis of the Influence of Antipsychotics on Cytokines Levels in First Episode Psychosis
por: Marcinowicz, Piotr, et al.
Publicado: (2021)

Treatment of Acute Psychosis with Second-Generation Antipsychotics in a Patient with Left Temporal Lobe Lesion
por: Shehane, Richard, et al.
Publicado: (2018)

Abnormal reward prediction-error signalling in antipsychotic naive individuals with first-episode psychosis or clinical risk for psychosis
por: Ermakova, Anna O., et al.
Publicado: (2018)

Tardive dyskinesia in a South Asian population with first episode psychosis treated with antipsychotics
por: Adam, Usman U, et al.
Publicado: (2014)

S19. THE ROLE OF ACE AS POSSIBLE BIOMARKER FOR TREATMENT RESISTANCE TO ANTIPSYCHOTICS IN FIRST EPISODE OF PSYCHOSIS
por: Luisa, Longo, et al.
Publicado: (2020)

Prescribing pattern of antipsychotic medication for first-episode psychosis: a retrospective cohort study
por: Keating, Dolores, et al.
Publicado: (2021)

Macroscale EEG characteristics in antipsychotic-naïve patients with first-episode psychosis and healthy controls
por: Dominicus, L. S., et al.
Publicado: (2023)

Hippocampal glutamate and hippocampus subfield volumes in antipsychotic-naive first episode psychosis subjects and relationships to duration of untreated psychosis
por: Briend, Frédéric, et al.
Publicado: (2020)

White Matter Integrity, Duration of Untreated Psychosis, and Antipsychotic Treatment Response in Medication-Naïve First Episode Psychosis Patients
por: Kraguljac, Nina Vanessa, et al.
Publicado: (2020)

Cannabis and First-Episode Psychosis: Different Long-term Outcomes Depending on Continued or Discontinued Use
por: González-Pinto, Ana, et al.
Publicado: (2011)

Second Generation Antipsychotics in the Treatment of Major Depressive Disorder: An Update
por: Wang, Sheng-Min, et al.
Publicado: (2016)

Updating the Comparative Evidence on Second‐Generation Antipsychotic Use With Schizophrenia
por: McDonagh, Marian S., et al.
Publicado: (2020)

Role of Long-Acting Injectable Second-Generation Antipsychotics in the Treatment of First-Episode Schizophrenia: A Clinical Perspective
por: Přikryl, Radovan, et al.
Publicado: (2012)

To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial
por: Begemann, Marieke J. H., et al.
Publicado: (2020)

Guidelines for Discontinuation of Antipsychotics in Patients Who Recover From First-Episode Schizophrenia Spectrum Disorders: Derived From the Aggregated Opinions of Asian Network of Early Psychosis Experts and Literature Review
Publicado: (2022)

Remission from antipsychotic treatment in first episode psychosis related to longitudinal changes in brain glutamate
por: Merritt, Kate, et al.
Publicado: (2019)

Glyceryl trinitrate in first-episode psychosis unmedicated with antipsychotics: A randomised controlled pilot study
por: Merritt, Kate, et al.
Publicado: (2020)

Relationship Between Serum NMDA Receptor Antibodies and Response to Antipsychotic Treatment in First-Episode Psychosis
por: Pollak, Thomas A., et al.
Publicado: (2021)

Patterns of antipsychotic prescribing in first episode psychosis – differences between acute and early intervention services
por: Fallon, James, et al.
Publicado: (2021)

Insulin resistance in first episode antipsychotic naïve psychosis patients-A cross sectional study.
por: Akshatha, C J, et al.
Publicado: (2022)

Dose Reduction/Discontinuation of Antipsychotic Drugs in Psychosis; Effect on Cognition and Functional Outcomes
por: Omachi, Yoshie, et al.
Publicado: (2018)

QTc Prolongation in Patients Acutely Admitted to Hospital for Psychosis and Treated with Second Generation Antipsychotics
por: Johnsen, Erik, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_7ga6eh2oc25jdjuuks5a6kl4g2